Ready to supercharge your portfolio in 2026? Citigroup has just unveiled its top market sectors for the coming year, and the picks might surprise you. But here's where it gets controversial: while some sectors have been on a tear in 2025, Citi is betting on a shift in focus that could leave some investors scratching their heads. And this is the part most people miss: it's not just about riding the wave of this year's winners, but positioning for what's next. Here’s the breakdown, along with Citi's top stock picks for each sector.
By Jennifer Sor
As we step into 2026, Citigroup's investment research arm has identified three key areas where investors should consider overweighting their portfolios: Information Technology, Financials, and Healthcare. But why these sectors? And what makes Citi's picks stand out?
Information Technology: The Growth Engine
Citi researchers highlight the sector's strong fundamentals, particularly in semiconductors, where growth prospects look 'attractive.' Additionally, positive earnings revisions in software and services add to the optimism. Interestingly, not all valuations in this space are sky-high, making it a compelling growth sector for 2026. But is the tech boom sustainable, or are we on the cusp of a correction?
Top Picks:
- Oracle Corp (ORCL): +17% return in 2025
- DocuSign Inc (DOCU): -22% return in 2025
- ServiceNow Inc (NOW): -27% return in 2025
Financials: Steady Earnings Amid Uncertainty
Despite lagging the broader market in 2025 with a 6% gain, the financials sector shows promise. Citi points to 'healthy' profit margins for banks and positive trading signals, including a favorable Relative Strength Index reading. But with interest rates and economic policies in flux, can financials truly outperform in 2026?
Top Picks:
- Payoneer Global Inc (PAYO): -41% return in 2025
- Block Inc (XYZ): -24% return in 2025
- Ally Financial (ALLY): +27% return in 2025
Healthcare: Policy Clarity on the Horizon
The healthcare sector has been a standout performer in 2025, up 17% year-to-date. Citi expects investor sentiment to improve further as policy uncertainties, such as drug pricing, begin to clear. Insider buying has increased, while selling has tapered off, signaling confidence in the sector's prospects. But with healthcare policy still a hot-button issue, is this optimism warranted?
Top Picks:
- Arcus Biosciences Inc (RCUS): +53% return in 2025
- Waystar Holding Corp (WAY): -11% return in 2025
- Neurocrine Biosciences Inc (NBIX): +8% return in 2025
Citi's Strategy: Balancing Growth and Defense
In 2025, Citi's portfolio outperformed the S&P 500 by over four percentage points, thanks to its focus on growth sectors and a cyclical barbell strategy. For 2026, the bank is shifting toward a more balanced approach, incorporating defensive sectors to align with expectations of broader fundamental growth. Is this the right move, or should investors double down on growth?
Final Thoughts and Your Turn
Citi's 2026 picks offer a mix of growth, stability, and potential turnaround opportunities. But as with any investment strategy, there are no guarantees. What do you think? Are Citi's picks spot on, or are there sectors and stocks you'd bet on instead? Share your thoughts in the comments below!
